Lista de obras - Madia Lozupone - Dominio Público Uruguay

A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease

scientific article published on 01 February 2019

Additive Role of a Potentially Reversible Cognitive Frailty Model and Inflammatory State on the Risk of Disability: The Italian Longitudinal Study on Aging

artículo científico publicado en 2017

Amyloid-β immunotherapy for alzheimer disease: Is it now a long shot?

scientific article published on 28 January 2019

An Old Challenge with New Promises: A Systematic Review on Comprehensive Geriatric Assessment in Long-Term Care Facilities

artículo científico

Apolipoprotein E genotype, inflammatory biomarkers, and non-psychiatric multimorbidity contribute to the suicidal ideation phenotype in older age. The Salus in Apulia Study

artículo científico publicado en 2022

Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?

artículo científico publicado en 2019

BACE inhibitors in clinical development for the treatment of Alzheimer's disease

article

Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging

scientific article published on 02 July 2019

Bipolar Disorder and Frontotemporal Dementia: An Intriguing Association.

artículo científico publicado en 2017

Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke

scientific article published on 01 February 2019

Cognitive frailty: a potential target for secondary prevention of dementia

artículo científico publicado en 2017

Corrigendum to "Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review" Neurosci. Biobehav. Rev. 95 (2018) 480-498

scientific article published on 05 December 2019

Development of disease-modifying drugs for frontotemporal dementia spectrum disorders

artículo científico publicado en 2020

Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention.

artículo científico publicado en 2018

Discontinued disease-modifying therapies for Alzheimer's disease: status and future perspectives

scientific article published on 11 July 2020

Disease-modifying therapies for tauopathies: agents in the pipeline

scientific article published on 25 April 2019

Do BACE inhibitor failures in Alzheimer patients challenge the amyloid hypothesis of the disease?

artículo científico publicado en 2019

Do anti-amyloid-β drugs affect neuropsychiatric status in Alzheimer's disease patients?

scientific article published on 24 August 2019

Emerging biomarkers and screening for cognitive frailty

artículo científico publicado en 2017

Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients.

artículo científico publicado en 2016

Episodic memory and learning rates in amyotrophic lateral sclerosis without dementia

artículo científico publicado en 2019

Examination of level of knowledge in Italian general practitioners attending an education session on diagnosis and management of the early stage of Alzheimer's disease: pass or fail?

artículo científico publicado en 2016

Executive Dysfunction Detected with the Frontal Assessment Battery in Alzheimer's Disease Versus Vascular Dementia.

artículo científico publicado en 2018

Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance

artículo científico publicado en 2010

Genetics of tailored medicine: Focus on CNS drugs

article

High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective?

artículo científico publicado en 2016

Hydroxytryptamine transporter gene-linked polymorphic region (5HTTLPR) is associated with delusions in Alzheimer's disease

article

Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry.

artículo científico publicado en 2017

Klotho Gene and Selective Serotonin Reuptake Inhibitors: Response to Treatment in Late-Life Major Depressive Disorder

artículo científico publicado en 2016

Late-onset depression is associated to age-related central auditory processing disorder in an older population in Southern Italy

scientific article published on 31 October 2020

Liver Fibrosis and Hearing Loss in an Older Mediterranean Population: Results from the Salus in Apulia Study

scientific article published in 2022

Metabolic syndrome: differences between psychiatric and internal medicine patients

artículo científico publicado en 2013

Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline.

artículo científico publicado en 2017

Motoric Cognitive Risk Syndrome, Subtypes and 8-Year All-Cause Mortality in Aging Phenotypes: The Salus in Apulia Study

artículo científico publicado en 2022

Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review

artículo científico publicado en 2018

Nutritional Interventions and Cognitive-related Outcomes in Patients with Late-life Cognitive Disorders: A Systematic Review

artículo científico publicado en 2018

Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline

artículo científico publicado en 2019

Pharmacogenetics of neurological and psychiatric diseases at older age: has the time come?

artículo científico publicado en 2016

Pharmacological management of dementia with Lewy bodies with a focus on zonisamide for treating parkinsonism

artículo científico publicado en 2020

Pharmacotherapy for the treatment of depression in patients with alzheimer's disease: a treatment-resistant depressive disorder

artículo científico publicado en 2018

Progresses in treating agitation: a major clinical challenge in Alzheimer's disease

artículo científico

Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs

scientific article published on 19 April 2019

Psychiatry meets pharmacogenetics for the treatment of revolving door patients with psychiatric disorders

artículo científico publicado en 2016

Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis

artículo científico publicado en 2013

Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know?

artículo científico publicado en 2017

Relationship between Inflammatory Food Consumption and Age-Related Hearing Loss in a Prospective Observational Cohort: Results from the Salus in Apulia Study

scientific article published on 07 February 2020

Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review.

artículo científico publicado en 2017

Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging

artículo científico publicado en 2017

Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer's Disease

artículo científico publicado en 2017

Sensorial frailty: age-related hearing loss and the risk of cognitive impairment and dementia in later life

scientific article published on 09 November 2018

Social Dysfunction in Older Age and Relationships with Cognition, Depression, and Apathy: The GreatAGE Study

artículo científico publicado en 2018

Social determinants of late-life depression epigenetics

scientific article published on 12 May 2020

Tau aggregation inhibitors: the future of Alzheimer's pharmacotherapy?

artículo científico publicado en 2016

Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease

artículo científico publicado en 2016

Tau-based therapeutics for Alzheimer's disease: active and passive immunotherapy

artículo científico publicado en 2016

Tau-directed approaches for the treatment of Alzheimer's disease: focus on leuco-methylthioninium

artículo científico publicado en 2016

The Age-Related Central Auditory Processing Disorder: Silent Impairment of the Cognitive Ear.

artículo científico publicado en 2019

The Role of Biomarkers in Psychiatry

scientific article published on 01 January 2019

The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset

artículo científico publicado en 2017

The relationship between epigenetics and microbiota in neuropsychiatric diseases

artículo científico publicado en 2020

Time to test antibacterial therapy in Alzheimer's disease

artículo científico publicado en 2019

Traditional Dietary Patterns and Risk of Mortality in a Longitudinal Cohort of the Salus in Apulia Study

scientific article published on 12 April 2020

Understanding frailty to predict and prevent dementia

scientific article published on 01 February 2019

Lista de obras de Madia Lozupone

A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease

Additive Role of a Potentially Reversible Cognitive Frailty Model and Inflammatory State on the Risk of Disability: The Italian Longitudinal Study on Aging

Amyloid-β immunotherapy for alzheimer disease: Is it now a long shot?

An Old Challenge with New Promises: A Systematic Review on Comprehensive Geriatric Assessment in Long-Term Care Facilities

Apolipoprotein E genotype, inflammatory biomarkers, and non-psychiatric multimorbidity contribute to the suicidal ideation phenotype in older age. The Salus in Apulia Study

Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?

BACE inhibitors in clinical development for the treatment of Alzheimer's disease

Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging

Bipolar Disorder and Frontotemporal Dementia: An Intriguing Association.

Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke

Cognitive frailty: a potential target for secondary prevention of dementia

Corrigendum to "Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review" Neurosci. Biobehav. Rev. 95 (2018) 480-498

Development of disease-modifying drugs for frontotemporal dementia spectrum disorders

Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention.

Discontinued disease-modifying therapies for Alzheimer's disease: status and future perspectives

Disease-modifying therapies for tauopathies: agents in the pipeline

Do BACE inhibitor failures in Alzheimer patients challenge the amyloid hypothesis of the disease?

Do anti-amyloid-β drugs affect neuropsychiatric status in Alzheimer's disease patients?

Emerging biomarkers and screening for cognitive frailty

Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients.

Episodic memory and learning rates in amyotrophic lateral sclerosis without dementia

Examination of level of knowledge in Italian general practitioners attending an education session on diagnosis and management of the early stage of Alzheimer's disease: pass or fail?

Executive Dysfunction Detected with the Frontal Assessment Battery in Alzheimer's Disease Versus Vascular Dementia.

Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance

Genetics of tailored medicine: Focus on CNS drugs

High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective?

Hydroxytryptamine transporter gene-linked polymorphic region (5HTTLPR) is associated with delusions in Alzheimer's disease

Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry.

Klotho Gene and Selective Serotonin Reuptake Inhibitors: Response to Treatment in Late-Life Major Depressive Disorder

Late-onset depression is associated to age-related central auditory processing disorder in an older population in Southern Italy

Liver Fibrosis and Hearing Loss in an Older Mediterranean Population: Results from the Salus in Apulia Study

Metabolic syndrome: differences between psychiatric and internal medicine patients

Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline.

Motoric Cognitive Risk Syndrome, Subtypes and 8-Year All-Cause Mortality in Aging Phenotypes: The Salus in Apulia Study

Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review

Nutritional Interventions and Cognitive-related Outcomes in Patients with Late-life Cognitive Disorders: A Systematic Review

Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline

Pharmacogenetics of neurological and psychiatric diseases at older age: has the time come?

Pharmacological management of dementia with Lewy bodies with a focus on zonisamide for treating parkinsonism

Pharmacotherapy for the treatment of depression in patients with alzheimer's disease: a treatment-resistant depressive disorder

Progresses in treating agitation: a major clinical challenge in Alzheimer's disease

Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs

Psychiatry meets pharmacogenetics for the treatment of revolving door patients with psychiatric disorders

Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis

Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know?

Relationship between Inflammatory Food Consumption and Age-Related Hearing Loss in a Prospective Observational Cohort: Results from the Salus in Apulia Study

Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review.

Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging

Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer's Disease

Sensorial frailty: age-related hearing loss and the risk of cognitive impairment and dementia in later life

Social Dysfunction in Older Age and Relationships with Cognition, Depression, and Apathy: The GreatAGE Study

Social determinants of late-life depression epigenetics

Tau aggregation inhibitors: the future of Alzheimer's pharmacotherapy?

Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease

Tau-based therapeutics for Alzheimer's disease: active and passive immunotherapy

Tau-directed approaches for the treatment of Alzheimer's disease: focus on leuco-methylthioninium

The Age-Related Central Auditory Processing Disorder: Silent Impairment of the Cognitive Ear.

The Role of Biomarkers in Psychiatry

The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset

The relationship between epigenetics and microbiota in neuropsychiatric diseases

Time to test antibacterial therapy in Alzheimer's disease

Traditional Dietary Patterns and Risk of Mortality in a Longitudinal Cohort of the Salus in Apulia Study

Understanding frailty to predict and prevent dementia